BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Y-Biologics & Pierre Fabre enter into an agreement in the field of immuno-oncology

These antibodies have been functionally validated by the Pierre Fabre R&D teams for their specific properties on a pivotal immuno-oncology target actin...

July 06, 2021 | News

BioMed X & Merck KGaA, Darmstad Launch New Research Program in Oncology

BioMed X Institute expands its collaboration with Merck KGaA, Darmstadt, Germany to a total of eight research programs. Call for application of ...

July 05, 2021 | News

QIAGEN Forms Strategic Alliance With Sysmex Corporation

Frankfurt Prime Standard:QIA) today announced a global strategic alliance with Japan’s Sysmex Corporation (Tokyo Stock Exchange, First Section [Ticke...

July 02, 2021 | News

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio

First patient dosed in U.S. phase 1 clinical trial of TJ-CD4B/ABL111 in patients with advanced or metastatic solid tumors China sites to join the d...

July 02, 2021 | News

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

OnCusp successfully closed its seed round financing of $25 million on April 1, 2021, led by Sequoia Capital and Biotrack Capital, followed b...

July 01, 2021 | News

B dot Medical to test on a compact proton cancer therapy system

To Realize Compact and Low-cost Proton Therapy System - B dot Medical Inc. has confirmed the superconductivity of a superconducting be...

June 28, 2021 | News

GenesisCare Expands their MR-guided Radiotherapy Reach

ViewRay, Inc. (NASDAQ: VRAY) today announced that GenesisCare has entered into a master purchase agreement for up to 14 MRIdian® MR-Guided Therapy Syst...

June 25, 2021 | News

Singapore to Introduce Fertility Preservation Services for Cancer Patients

Cancer treatments such as chemotherapy and radiation therapy can affect a woman's fertility by impacting the ovaries and other essential reproductive organ...

June 23, 2021 | News

Shimadzu ,Rakuten Medical to support cancer treatment by photoimmunotherapy

Therapies developed on the Illuminox platform involve administering a targeting moiety conjugated with one or more dyes, which is illuminated by light at a...

June 18, 2021 | News

Debiopharm and Ubix Therapeutics o Develop a New Anti-Cancer Modality -

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech co...

June 17, 2021 | News

Harbour BioMed and Dana-Farber to Advance Novel Biotherapies for Cancer Treatment

Harbour BioMed scientists and Dana-Farber researchers will be working together to develop novel oncologic drugs, including bispecific antibodies and CAR-T ...

June 16, 2021 | News

IN3BIO gains approval for Phase I/II clinical trial

IN3BIO will trial its innovative anti-EGF vaccine IN01, in combination with small molecule inhibitors (SMIs) in patients suffering from KRAS or NRAS (...

June 10, 2021 | News

NUS researchers develop world’s first blood test for real-time monitoring of cancer treatment success

Cancer patients who are undergoing targeted therapy can look forward to a new blood test that could tell their doctors whether the treatment is working, wi...

June 10, 2021 | News

Hummingbird Bioscience and Novogene to expand precision medicine testing

Partnership will enhance biomarker-driven patient enrollment in clinical trials of Hummingbird Bioscience's lead program, HMBD-001 Hummingbird Bioscience,...

June 09, 2021 | News

Stay Connected